PRELIMINARY PROGRAM
THOMAS L. PETTY
ASPEN LUNG CONFERENCE
55th Annual Meeting
June 6 - June 9, 2012
“MECHANICS AND MECHANISMS OF PULMONARY HYPERTENSION”
Todd M. Bull, M.D., Co-Chair
Kurt R. Stenmark, M.D., Co-Chair
TOPICS AND STATE OF THE ART SPEAKERS
“Development of the Pulmonary Vasculature and the Right Ventricle”
Edward E. Morrisey, Ph.D.
Philadelphia, Pennsylvania
“Metabolism, Bioenergetics and Pulmonary Hypertension”
Stephen L. Archer, M.D.
Chicago, Illinois
“Right Ventricular Failure”
Norbert F. Voelkel, M.D.
Richmond, Virginia
“Right Ventricle-Pulmonary Artery Coupling”
Hunter C. Champion, M.D., Ph.D.
Pittsburgh, Pennsylvania
“The Role of Inflammation in Pulmonary Hypertension”
Professor Marc Humbert, M.D., Ph.D.
Paris, France
“Imaging Biomarkers for Cardiopulmonary Disease – From Man to Mouse”
G. Allen Johnson, Ph.D.
Durham, North Carolina
“Mechanisms of Development of COPD Associated Pulmonary Hypertension”
Professor Joan A. Barbera, M.D., Ph.D.
Barcelona, Spain
“HIV, Herpes Virus Infections and Pulmonary Vascular Disease”
Sonia C. Flores, Ph.D.
Aurora, Colorado
“Genetics, Genomics and Epigenetics of Pulmonary Hypertension”
Mark W. Geraci, M.D.
Aurora, Colorado
“Potential of Developing Stage Directed Therapies for Lung Diseases with Mesenchymal
Stem Cells or the Therapeutic Proteins They Produce”
Darwin J. Prockop, M.D., Ph.D.
Temple, Texas
“IPS Stem Cells and Pulmonary Hypertension”
Marlene Rabinovitch, M.D.
Palo Alto, California
“Developing Therapies for Pulmonary Hypertension”
Professor Martin R. Wilkins, M.D.
London, England
CONFERENCE SUMMARY
Professor Werner Seeger, M.D.
Giessen, Germany